GlycoMimetics
AcquiredHome - Crescent Biopharma
- Employees
- 11–50
- Business Model
- B2B
- Website
- glycomimetics.com
- Total Funding
- $38.0M
- Last Round
- $38.0M Venture Round
- Rounds
- 1
About
GlycoMimetics was a Rockville, Maryland-based clinical-stage biotechnology company that discovered and developed glycobiology-based therapies targeting cancers and inflammatory diseases. Its leading program uproleselan targeted E-selectin in acute myeloid leukemia. In June 2025, GlycoMimetics merged with Crescent Biopharma.
Summary
It has raised $38.0M in total across 1 round. Investors include Sanofi Ventures, Fairmount and Venrock.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
